Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 5MG | TABLET | Resolved | 2019-08-23 | 2020-01-22 | 92387 |
APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2019-08-28 | 2020-09-09 | 92513 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-28 | 2019-12-20 | 92525 |
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Resolved | 2019-09-04 | 2020-01-07 | 92962 |
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-09-04 | 2019-10-15 | 92965 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-04 | 2019-10-28 | 92968 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-04 | 2019-11-11 | 92971 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-09-04 | 2019-09-06 | 92974 |
APO-LAMOTRIGINE | 25MG | TABLET | Resolved | 2019-09-04 | 2020-01-29 | 92978 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-09-04 | 2019-12-19 | 92981 |
APO-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-09-04 | 2019-10-01 | 92984 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-09-04 | 2019-11-21 | 92989 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2019-09-04 | 2020-07-29 | 92992 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-09-09 | 2019-09-16 | 93262 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2019-09-12 | 2019-10-18 | 93665 |
APO-CARVEDILOL | 25MG | TABLET | Resolved | 2019-09-12 | 2020-09-21 | 93668 |
APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-09-12 | 2019-10-01 | 93671 |
APO-ENALAPRIL | 5MG | TABLET | Resolved | 2019-09-18 | 2019-12-19 | 94168 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-09-18 | 2019-11-25 | 94171 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |